CD8 T-cell reactivity to islet antigens is unique to type 1 while CD4 T-cell reactivity exists in both type 1 and type 2 diabetes

Journal of Autoimmunity - Tập 50 - Trang 77-82 - 2014
Ghanashyam Sarikonda1, Jeremy Pettus1,2, Sonal Phatak2, Sowbarnika Sachithanantham1, Jacqueline F. Miller1, Johnna D. Wesley3, Eithon Cadag4, Ji Chae5, Lakshmi Ganesan2, Ronna Mallios1, Steve Edelman6, Bjoern Peters1, Matthias von Herrath1,3
1La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA
2University of California, San Diego, San Diego, CA, USA
3Novo Nordisk Type 1 Diabetes R & D Center, Seattle, WA, USA
4Ayasdi, Inc., Palo Alto, CA, USA
5University of California—San Diego, San Diego, CA, USA
6University of California San Diego, San Diego, CA, USA

Tài liệu tham khảo

Fox, 2006, Trends in the incidence of type 2 diabetes mellitus from the 1970s to the 1990s: the Framingham Heart Study, Circulation, 113, 2914, 10.1161/CIRCULATIONAHA.106.613828 Gale, 2002, The rise of childhood type 1 diabetes in the 20th century, Diabetes, 51, 3353, 10.2337/diabetes.51.12.3353 Eisenbarth, 1986, Type I diabetes mellitus. A chronic autoimmune disease, N Engl J Med, 314, 1360, 10.1056/NEJM198605223142106 Rahier, 2008, Pancreatic beta-cell mass in European subjects with type 2 diabetes, Diabetes Obes Metab, 10, 32, 10.1111/j.1463-1326.2008.00969.x Saisho, 2007, Pancreas volumes in humans from birth to age one hundred taking into account sex, obesity, and presence of type-2 diabetes, Clin Anat, 20, 933, 10.1002/ca.20543 Pietropaolo, 2000, Evidence of islet cell autoimmunity in elderly patients with type 2 diabetes, Diabetes, 49, 32, 10.2337/diabetes.49.1.32 Winer, 2011, B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies, Nat Med, 17, 610, 10.1038/nm.2353 Mallone, 2013, Biomarkers for immune intervention trials in type 1 diabetes, Clin Immunol, 149, 286, 10.1016/j.clim.2013.02.009 Arif, 2004, Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health, J Clin Invest, 113, 451, 10.1172/JCI19585 Long, 2010, Defects in IL-2R signaling contribute to diminished maintenance of FOXP3 expression in CD4(+)CD25(+) regulatory T-cells of type 1 diabetic subjects, Diabetes, 59, 407, 10.2337/db09-0694 Penaranda, 2011, Anti-CD3 therapy promotes tolerance by selectively depleting pathogenic cells while preserving regulatory T cells, J Immunol, 187, 2015, 10.4049/jimmunol.1100713 Velthuis, 2010, Simultaneous detection of circulating autoreactive CD8+ T-cells specific for different islet cell-associated epitopes using combinatorial MHC-multimers, Diabetes, 59, 1721, 10.2337/db09-1486 Roep, 2010, Surrogate end points in the design of immunotherapy trials: emerging lessons from type 1 diabetes, Nat Rev Immunol, 10, 145, 10.1038/nri2705 von Herrath, 2007, Type 1 diabetes as a relapsing-remitting disease?, Nat Rev Immunol, 7, 988, 10.1038/nri2192 Sanda, 2008, Islet antigen specific IL-10+ immune responses but not CD4+CD25+FoxP3+ cells at diagnosis predict glycemic control in type 1 diabetes, Clin Immunol, 127, 138, 10.1016/j.clim.2007.12.003 Oseroff, 2012, T cell responses to known allergen proteins are differently polarized and account for a variable fraction of total response to allergen extracts, J Immunol, 189, 1800, 10.4049/jimmunol.1200850 Fennessy, 1994, A gene in the HLA class I region contributes to susceptibility to IDDM in the Finnish population. Childhood Diabetes in Finland (DiMe) Study Group, Diabetologia, 37, 937, 10.1007/BF00400951 Nerup, 1974, HL-A antigens and diabetes mellitus, Lancet, 2, 864, 10.1016/S0140-6736(74)91201-X Park, 1998, Combinations of HLA DR and DQ molecules determine the susceptibility to insulin-dependent diabetes mellitus in Koreans, Hum Immunol, 59, 794, 10.1016/S0198-8859(98)00076-7 Brooks-Worrell, 2011, Identification of autoantibody-negative autoimmune type 2 diabetic patients, Diabetes Care, 34, 168, 10.2337/dc10-0579 Cnop, 2005, Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities, Diabetes, 54, S97, 10.2337/diabetes.54.suppl_2.S97 Carlsson, 2009, Topology and data, Bull Am Math Soc, 46, 255, 10.1090/S0273-0979-09-01249-X Lum, 2013, Extracting insights from the shape of complex data using topology, Sci Reports, 3, 1236, 10.1038/srep01236 Gloyn, 2001, Association studies of variants in promoter and coding regions of beta-cell ATP-sensitive K-channel genes SUR1 and Kir6.2 with Type 2 diabetes mellitus (UKPDS 53), Diabet Med, 18, 206, 10.1046/j.1464-5491.2001.00449.x Gloyn, 2003, Large-scale association studies of variants in genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes, Diabetes, 52, 568, 10.2337/diabetes.52.2.568 Hani, 1998, Missense mutations in the pancreatic islet beta cell inwardly rectifying K+ channel gene (KIR6.2/BIR): a meta-analysis suggests a role in the polygenic basis of Type II diabetes mellitus in Caucasians, Diabetologia, 41, 1511, 10.1007/s001250051098 Filippi, 2005, How viral infections affect the autoimmune process leading to type 1 diabetes, Cell Immunol, 233, 125, 10.1016/j.cellimm.2005.04.009 Filippi, 2008, Viral trigger for type 1 diabetes: pros and cons, Diabetes, 57, 2863, 10.2337/db07-1023 Coppieters, 2012, Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients, J Exp Med, 209, 51, 10.1084/jem.20111187 Skog, 2013, Revisiting the notion of type 1 diabetes being a T-cell-mediated autoimmune disease, Curr Opin Endocrinol Diabetes Obes, 20, 118, 10.1097/MED.0b013e32835edb89 Keenan, 2010, Residual insulin production and pancreatic ss-cell turnover after 50 years of diabetes: Joslin Medalist Study, Diabetes, 59, 2846, 10.2337/db10-0676